Here are six insights:
1. Zacks has a $0.25 target price on the stock.
2. Zacks’ price objective sees an upside of 78.57 percent from the stock’s current price.
3. Cytori shares opened at 0.14 on Feb. 9.
4. The market cap is $22.19 million.
5. The company has a 52-week low of $0.14 and a 52-week high of $1.47.
6. The 50-day moving average is $0.18 and the 200-day moving average is $0.32.
More articles on devices:
FDA schedules meeting to review Cartiva’s PMA for synthetic cartilage implant: 4 points
Zimmer Biomet investors to offer 11M+ shares of common stock: 5 takeaways
Smith & Nephew insider sells 11k+ shares: 4 facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
